Click here to get full coverage on REVB SEC Filings - Revelation Biosciences 10-K, 10-Q, 8-K Forms - Stock Titan

REVB SEC Filings - Revelation Biosciences 10-K, 10-Q, 8-K Forms  Stock Titan

REVB SEC Filings - Revelation Biosciences 10-K, 10-Q, 8-K Forms - Stock Titan

Click here to get full coverage on REVB Technical Analysis & Stock Price Forecast - Intellectia AI

REVB Technical Analysis & Stock Price Forecast  Intellectia AI

REVB Technical Analysis & Stock Price Forecast - Intellectia AI

Click here to get full coverage on Revelation Biosciences (REVB) price target decreased by 37.65% to 54.06 - MSN

Revelation Biosciences (REVB) price target decreased by 37.65% to 54.06  MSN

Revelation Biosciences (REVB) price target decreased by 37.65% to 54.06 - MSN

Click here to get full coverage on REVB Stock Drops 10% After Company Announces Third Reverse Split In A Year - stocktwits.com

REVB Stock Drops 10% After Company Announces Third Reverse Split In A Year  stocktwits.com

REVB Stock Drops 10% After Company Announces Third Reverse Split In A Year - stocktwits.com

Click here to get full coverage on Why Did Revelation Biosciences (REVB) Stock Jump Over 25% After-Hours? - Benzinga

Why Did Revelation Biosciences (REVB) Stock Jump Over 25% After-Hours?  Benzinga

Why Did Revelation Biosciences (REVB) Stock Jump Over 25% After-Hours? - Benzinga

Click here to get full coverage on Revelation Biosciences, Inc. (REVB) Raises $4M in Public Offering - Yahoo Finance

Revelation Biosciences, Inc. (REVB) Raises $4M in Public Offering  Yahoo Finance

Revelation Biosciences, Inc. (REVB) Raises $4M in Public Offering - Yahoo Finance

Click here to get full coverage on Revelation Biosciences (REVB) stock ticks up premarket after FDA lays out Gemini trial path - TechStock²

Revelation Biosciences (REVB) stock ticks up premarket after FDA lays out Gemini trial path  TechStock²

Revelation Biosciences (REVB) stock ticks up premarket after FDA lays out Gemini trial path - TechStock²

Click here to get full coverage on If You Invested $1,000 in Revelation Biosciences (REVB) - Stock Titan

If You Invested $1,000 in Revelation Biosciences (REVB)  Stock Titan

If You Invested $1,000 in Revelation Biosciences (REVB) - Stock Titan

Click here to get full coverage on Revelation Biosciences to implement 1-for-4 reverse stock split - Investing.com

Revelation Biosciences to implement 1-for-4 reverse stock split  Investing.com

Revelation Biosciences to implement 1-for-4 reverse stock split - Investing.com

Click here to get full coverage on A single Gemini dose restored immune response for 7 days in CKD study - Stock Titan

A single Gemini dose restored immune response for 7 days in CKD study  Stock Titan

A single Gemini dose restored immune response for 7 days in CKD study - Stock Titan

Click here to get full coverage on Revelation Biosciences announces warrant exercise agreement - Investing.com

Revelation Biosciences announces warrant exercise agreement  Investing.com

Revelation Biosciences announces warrant exercise agreement - Investing.com

Click here to get full coverage on Revelation Biosciences' Roth fireside chat streams live at 2 p.m. PT - Stock Titan

Revelation Biosciences' Roth fireside chat streams live at 2 p.m. PT  Stock Titan

Revelation Biosciences' Roth fireside chat streams live at 2 p.m. PT - Stock Titan

Click here to get full coverage on Revelation Biosciences trades new 5-year warrants for $11M cash - Stock Titan

Revelation Biosciences trades new 5-year warrants for $11M cash  Stock Titan

Revelation Biosciences trades new 5-year warrants for $11M cash - Stock Titan

Click here to get full coverage on Revelation Biosciences (NASDAQ: REVB) clears Class J warrant share issuance - Stock Titan

Revelation Biosciences (NASDAQ: REVB) clears Class J warrant share issuance  Stock Titan

Revelation Biosciences (NASDAQ: REVB) clears Class J warrant share issuance - Stock Titan

Click here to get full coverage on Kidney drug Gemini advances at Revelation, cash runway into 2027 - Stock Titan

Kidney drug Gemini advances at Revelation, cash runway into 2027  Stock Titan

Kidney drug Gemini advances at Revelation, cash runway into 2027 - Stock Titan

Click here to get full coverage on Revelation Biosciences CEO, CFO to appear in Mar. 24 webcast chat - Stock Titan

Revelation Biosciences CEO, CFO to appear in Mar. 24 webcast chat  Stock Titan

Revelation Biosciences CEO, CFO to appear in Mar. 24 webcast chat - Stock Titan

Click here to get full coverage on Revelation Biosciences to combine 4 shares into 1 for Nasdaq bid - Stock Titan

Revelation Biosciences to combine 4 shares into 1 for Nasdaq bid  Stock Titan

Revelation Biosciences to combine 4 shares into 1 for Nasdaq bid - Stock Titan

Click here to get full coverage on FDA, Revelation map single trial for deadly kidney injury drug - Stock Titan

FDA, Revelation map single trial for deadly kidney injury drug  Stock Titan

FDA, Revelation map single trial for deadly kidney injury drug - Stock Titan

Click here to get full coverage on Biotech recruits new employee with 90,000 stock units over 2 years - Stock Titan

Biotech recruits new employee with 90,000 stock units over 2 years  Stock Titan

Biotech recruits new employee with 90,000 stock units over 2 years - Stock Titan

Click here to get full coverage on Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference - Fresno Bee

Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference  Fresno Bee

Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference - Fresno Bee

Click here to get full coverage on Revelation Biosciences Stock Slides 17% After Company Reports 3 Severe Adverse Events In Early Stage Trial Of Inflammation Drug - stocktwits.com

Revelation Biosciences Stock Slides 17% After Company Reports 3 Severe Adverse Events In Early Stage Trial Of Inflammation Drug  stocktwits.com

Revelation Biosciences Stock Slides 17% After Company Reports 3 Severe Adverse Events In Early Stage Trial Of Inflammation Drug - stocktwits.com

Click here to get full coverage on Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds - newswire.com

Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds  newswire.com

Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds - newswire.com

Click here to get full coverage on REVB Forecast — Price Prediction for 2026. Should I Buy REVB? - Intellectia AI

REVB Forecast — Price Prediction for 2026. Should I Buy REVB?  Intellectia AI

REVB Forecast — Price Prediction for 2026. Should I Buy REVB? - Intellectia AI

Click here to get full coverage on FLiP Multicore Module Rev B Adds USB-C and Expanded Power Input - LinuxGizmos.com

FLiP Multicore Module Rev B Adds USB-C and Expanded Power Input  LinuxGizmos.com

FLiP Multicore Module Rev B Adds USB-C and Expanded Power Input - LinuxGizmos.com

Click here to get full coverage on Revelation Biosciences Inc. Announces 1-for-3 Reverse Stock Split Effective July 7, 2025 - Business Wire

Revelation Biosciences Inc. Announces 1-for-3 Reverse Stock Split Effective July 7, 2025  Business Wire

Revelation Biosciences Inc. Announces 1-for-3 Reverse Stock Split Effective July 7, 2025 - Business Wire

Click here to get full coverage on REVB Should I Buy - Intellectia AI

REVB Should I Buy - Intellectia AI

Click here to get full coverage on Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI - newswire.com

Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI  newswire.com

Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI - newswire.com

Click here to get full coverage on Why Revelation Biosciences Inc. (REVB) Went Down On Thursday? - Yahoo Finance

Why Revelation Biosciences Inc. (REVB) Went Down On Thursday?  Yahoo Finance

Why Revelation Biosciences Inc. (REVB) Went Down On Thursday? - Yahoo Finance

Click here to get full coverage on Revelation Biosciences Gains Momentum as FDA Agreement Sparks Hope - StocksToTrade

Revelation Biosciences Gains Momentum as FDA Agreement Sparks Hope  StocksToTrade

Revelation Biosciences Gains Momentum as FDA Agreement Sparks Hope - StocksToTrade

Click here to get full coverage on 1/27/2026 Market Update - Winners: REVB, XHLD, GITS - Losers: TWNP, FAT, CRDF - S&P 500: 0.4% - Trefis

1/27/2026 Market Update - Winners: REVB, XHLD, GITS - Losers: TWNP, FAT, CRDF - S&P 500: 0.4%  Trefis

1/27/2026 Market Update - Winners: REVB, XHLD, GITS - Losers: TWNP, FAT, CRDF - S&P 500: 0.4% - Trefis

Click here to get full coverage on Investors Aren't Entirely Convinced By Revolution Beauty Group plc's (LON:REVB) Revenues - simplywall.st

Investors Aren't Entirely Convinced By Revolution Beauty Group plc's (LON:REVB) Revenues  simplywall.st

Investors Aren't Entirely Convinced By Revolution Beauty Group plc's (LON:REVB) Revenues - simplywall.st

Click here to get full coverage on Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study - newswire.com

Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study  newswire.com

Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study - newswire.com

Click here to get full coverage on Revelation Biosciences begins GMP manufacturing for GEMINI trials - Investing.com

Revelation Biosciences begins GMP manufacturing for GEMINI trials  Investing.com

Revelation Biosciences begins GMP manufacturing for GEMINI trials - Investing.com

Click here to get full coverage on Revelation Biosciences submits end-of-phase 1 package to FDA - Investing.com

Revelation Biosciences submits end-of-phase 1 package to FDA  Investing.com

Revelation Biosciences submits end-of-phase 1 package to FDA - Investing.com

Click here to get full coverage on Revelation Biosciences Shareholders Approve Warrant Share Issuance - TipRanks

Revelation Biosciences Shareholders Approve Warrant Share Issuance  TipRanks

Revelation Biosciences Shareholders Approve Warrant Share Issuance - TipRanks

Click here to get full coverage on Revolution Beauty Confirms Total Voting Rights at 869.7 Million Shares - The Globe and Mail

Revolution Beauty Confirms Total Voting Rights at 869.7 Million Shares  The Globe and Mail

Revolution Beauty Confirms Total Voting Rights at 869.7 Million Shares - The Globe and Mail

Click here to get full coverage on Revelation Biosciences Raises Capital via Warrant Inducement - TipRanks

Revelation Biosciences Raises Capital via Warrant Inducement  TipRanks

Revelation Biosciences Raises Capital via Warrant Inducement - TipRanks

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Revelation Biosciences to Implement 1-for-4 Reverse Stock Split - MarketScreener

Revelation Biosciences to Implement 1-for-4 Reverse Stock Split  MarketScreener

Revelation Biosciences to Implement 1-for-4 Reverse Stock Split - MarketScreener

Click here to get full coverage on Revelation Biosciences Announces Retirement of George Tidmarsh, MD, PhD from Board of Directors - Business Wire

Revelation Biosciences Announces Retirement of George Tidmarsh, MD, PhD from Board of Directors  Business Wire

Revelation Biosciences Announces Retirement of George Tidmarsh, MD, PhD from Board of Directors - Business Wire

Click here to get full coverage on Revelation Biosciences stockholders approve warrant issuance beyond Nasdaq cap By Investing.com - Investing.com South Africa

Revelation Biosciences stockholders approve warrant issuance beyond Nasdaq cap By Investing.com  Investing.com South Africa

Revelation Biosciences stockholders approve warrant issuance beyond Nasdaq cap By Investing.com - Investing.com South Africa

Click here to get full coverage on Revelation Biosciences: Is It Set To Recover? - StocksToTrade

Revelation Biosciences: Is It Set To Recover?  StocksToTrade

Revelation Biosciences: Is It Set To Recover? - StocksToTrade

Click here to get full coverage on Revolution Beauty losses double but returning founders eye quick turnaround | AIM:REVB - Proactive Investors

Revolution Beauty losses double but returning founders eye quick turnaround | AIM:REVB  Proactive Investors

Revolution Beauty losses double but returning founders eye quick turnaround | AIM:REVB - Proactive Investors

Click here to get full coverage on REVB Stock Price and Chart — NASDAQ:REVB - tradingview.com

REVB Stock Price and Chart — NASDAQ:REVB  tradingview.com

REVB Stock Price and Chart — NASDAQ:REVB - tradingview.com

Click here to get full coverage on Should You Investigate Revolution Beauty Group plc (LON:REVB) At UK£0.13? - Yahoo Finance

Should You Investigate Revolution Beauty Group plc (LON:REVB) At UK£0.13?  Yahoo Finance

Should You Investigate Revolution Beauty Group plc (LON:REVB) At UK£0.13? - Yahoo Finance

Click here to get full coverage on Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - USA Today

Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)  USA Today

Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - USA Today

Click here to get full coverage on Is It Too Late To Consider Buying Revolution Beauty Group plc (LON:REVB)? - simplywall.st

Is It Too Late To Consider Buying Revolution Beauty Group plc (LON:REVB)?  simplywall.st

Is It Too Late To Consider Buying Revolution Beauty Group plc (LON:REVB)? - simplywall.st

Click here to get full coverage on What is the current Price Target and Forecast for Revelation Biosciences (REVB) - Zacks Investment Research

What is the current Price Target and Forecast for Revelation Biosciences (REVB)  Zacks Investment Research

What is the current Price Target and Forecast for Revelation Biosciences (REVB) - Zacks Investment Research

Click here to get full coverage on REVB|Revelation Biosciences Inc|Price:1.230|Chg%:0.03 - TradingKey

REVB|Revelation Biosciences Inc|Price:1.230|Chg%:0.03  TradingKey

REVB|Revelation Biosciences Inc|Price:1.230|Chg%:0.03 - TradingKey

Click here to get full coverage on Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering - Stock Titan

Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering  Stock Titan

Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering - Stock Titan

Click here to get full coverage on Revelation Biosciences, Inc. (REVB) stock price, news, quote and history - Yahoo Finance Singapore

Revelation Biosciences, Inc. (REVB) stock price, news, quote and history  Yahoo Finance Singapore

Revelation Biosciences, Inc. (REVB) stock price, news, quote and history - Yahoo Finance Singapore

Click here to get full coverage on Why Is Revelation Biosciences (REVB) Stock Down 62% Today? - InvestorPlace

Why Is Revelation Biosciences (REVB) Stock Down 62% Today?  InvestorPlace

Why Is Revelation Biosciences (REVB) Stock Down 62% Today? - InvestorPlace

Click here to get full coverage on Revelation Biosciences, Inc. (REVB) stock price, news, quote and history - Yahoo Finance Australia

Revelation Biosciences, Inc. (REVB) stock price, news, quote and history  Yahoo Finance Australia

Revelation Biosciences, Inc. (REVB) stock price, news, quote and history - Yahoo Finance Australia

Click here to get full coverage on Revelation Bio's Kidney Disease Drug Gemini Receives FDA IND Approval for Phase 1b Trial - Stock Titan

Revelation Bio's Kidney Disease Drug Gemini Receives FDA IND Approval for Phase 1b Trial  Stock Titan

Revelation Bio's Kidney Disease Drug Gemini Receives FDA IND Approval for Phase 1b Trial - Stock Titan

Click here to get full coverage on Technical Analysis of Revolution Beauty Group plc (LSE:REVB) - tradingview.com

Technical Analysis of Revolution Beauty Group plc (LSE:REVB)  tradingview.com

Technical Analysis of Revolution Beauty Group plc (LSE:REVB) - tradingview.com

Click here to get full coverage on Revolution Beauty promotes interim COO Bob Holt to CEO role - Proactive financial news

Revolution Beauty promotes interim COO Bob Holt to CEO role  Proactive financial news

Revolution Beauty promotes interim COO Bob Holt to CEO role - Proactive financial news

Click here to get full coverage on Revolution Beauty acquires BH Cosmetics for US$3.9mln - Proactive financial news

Revolution Beauty acquires BH Cosmetics for US$3.9mln  Proactive financial news

Revolution Beauty acquires BH Cosmetics for US$3.9mln - Proactive financial news

Click here to get full coverage on Revelation Biosciences Inc. Announces Preclinical Biomarker Data Supporting Activity of REVTx-300 - BioSpace

Revelation Biosciences Inc. Announces Preclinical Biomarker Data Supporting Activity of REVTx-300  BioSpace

Revelation Biosciences Inc. Announces Preclinical Biomarker Data Supporting Activity of REVTx-300 - BioSpace

Click here to get full coverage on Revolution Beauty Group plc Share Price (REVB) ORD GBP0.01 | REVB - Hargreaves Lansdown

Revolution Beauty Group plc Share Price (REVB) ORD GBP0.01 | REVB  Hargreaves Lansdown

Revolution Beauty Group plc Share Price (REVB) ORD GBP0.01 | REVB - Hargreaves Lansdown

Click here to get full coverage on Revolution Beauty Share Price (REVB) - London South East

Revolution Beauty Share Price (REVB)  London South East

Revolution Beauty Share Price (REVB) - London South East

Click here to get full coverage on Researcher Discloses 10 Zero-Day Flaws in D-Link 850L Wireless Routers - The Hacker News

Researcher Discloses 10 Zero-Day Flaws in D-Link 850L Wireless Routers  The Hacker News

Researcher Discloses 10 Zero-Day Flaws in D-Link 850L Wireless Routers - The Hacker News

Click here to get full coverage on SiFive Rolls Out RISC-V HiFive1 Rev B Development Platform, $49 USD With FE310-G002 SoC - Phoronix

SiFive Rolls Out RISC-V HiFive1 Rev B Development Platform, $49 USD With FE310-G002 SoC  Phoronix

SiFive Rolls Out RISC-V HiFive1 Rev B Development Platform, $49 USD With FE310-G002 SoC - Phoronix

Click here to get full coverage on Objective2 USB DAC & Amplifier Rev.B by Mayflower - headfonics.com

Objective2 USB DAC & Amplifier Rev.B by Mayflower  headfonics.com

Objective2 USB DAC & Amplifier Rev.B by Mayflower - headfonics.com

Click here to get full coverage on Revolution Beauty investigation raises further red flags, shares remain suspended - Proactive Investors

Revolution Beauty investigation raises further red flags, shares remain suspended  Proactive Investors

Revolution Beauty investigation raises further red flags, shares remain suspended - Proactive Investors

Click here to get full coverage on Thermalright Macho 90 and Macho Rev. B Reviews - Bit-Tech

Thermalright Macho 90 and Macho Rev. B Reviews  Bit-Tech

Thermalright Macho 90 and Macho Rev. B Reviews - Bit-Tech

Click here to get full coverage on Revolution Beauty seeks truce in Boohoo boardroom battle - Proactive Investors

Revolution Beauty seeks truce in Boohoo boardroom battle  Proactive Investors

Revolution Beauty seeks truce in Boohoo boardroom battle - Proactive Investors

Click here to get full coverage on Sean H Fitzpatrick Net Worth (2026) - GuruFocus

Sean H Fitzpatrick Net Worth (2026)  GuruFocus

Sean H Fitzpatrick Net Worth (2026) - GuruFocus

Click here to get full coverage on Zygmont Chester Stanley Iii Net Worth (2026) - GuruFocus

Zygmont Chester Stanley Iii Net Worth (2026)  GuruFocus

REVB

Price Chart

Key Statistics

Technicals

About REVB

Latest News

REVB SEC Filings - Revelation Biosciences 10-K, 10-Q, 8-K Forms - Stock Titan

REVB Technical Analysis & Stock Price Forecast - Intellectia AI

Revelation Biosciences (REVB) price target decreased by 37.65% to 54.06 - MSN

Advanced Charts

Top Gainers

Top Losers